Blood products
Ended Awarded Last action
- Contract number
- W81K0225FA145
- Awardee
-
The Republic Of Korea National Red Cross UEI PWQUAWD9VUF3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $8,774
Award facts
- Contract value 100% obligated
- $8,773.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $8,774 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call order valued at $8,773.71 to The Republic of Korea National Red Cross, operating as Gyeonggi Blood Center Red Cross, for the procurement of blood products. This firm-fixed-price call is issued without a set-aside designation and is performance-based in South Korea, where the vendor's facilities are located. The award supports critical blood inventory requirements for Department of Defense medical operations, specifically serving U.S. military healthcare facilities in South Korea, including the Brian Allgood Army Community Hospital. The blood products supplied include apheresis platelets in 250-milliliter units, whole blood units, and other essential blood components tailored to military healthcare needs.
This call order is executed under a parent single-award BPA valued at $249,000 with a performance period from July 1, 2022 through June 30, 2027, established by the Defense Health Agency and the U.S. Army Medical Command. The parent BPA provides a streamlined procurement mechanism that enables rapid acquisition of essential blood inventory through flexible ordering while maintaining consistent medical readiness for Department of Defense personnel stationed abroad. Individual call orders under this BPA typically range from $8,000 to $12,000 and are issued on a quarterly or semi-annual basis as operational blood product requirements dictate.
Quick answers
Who was awarded contract W81K0225FA145?
W81K0225FA145 was awarded to The Republic Of Korea National Red Cross by Medical Command (Department of the Army) on October 2, 2025.
How much is contract W81K0225FA145 worth?
The government has obligated $8,774 on W81K0225FA145.
Which agency awarded contract W81K0225FA145?
Medical Command (Department of the Army) awarded W81K0225FA145, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA145 an order under another contract?
Yes. W81K0225FA145 is a BPA call under W81K0222A0009, a blanket purchase agreement.
Was contract W81K0225FA145 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award